glp-1 drugs for parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications neurodegenerative treatment Are we measuring the wrong

edited and revised manuscript

No matter the reason someone is using these medications, people might experience some gastrointestinal (GI) discomfort, including: Constipation Diarrhea Nausea Vomiting These side effects are most common when people first start treatment or after a recent dosage adjustment

These publications are smaller in scope than our Special Health Reports, but they are written in the same clear, easy-to-understand language, and they provide the authoritative health advice you expect from Harvard Health Publishing

All strengths will be available from the manufacturer as the shortage has ended, but after April 22, 2025, compounding pharmacies will be only able to make custom doses